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Abstract
The reduced folate carrier (RFC1) is a major transporter for both natural reduced folates and antifolate
chemotherapeutics. Using polyclonal antibodies targeted to epitopes at the loop between the sixth and seventh predicted
transmembrane domains or the distal C-terminus, we were able to demonstrate by Western blot analysis that the molecular
size of RFC1 expressed in murine leukemia L1210 cells is 58 kDa as predicted by the open reading frame of its cDNA. 46-
and 38-kDa proteins detected only in plasma membrane preparations were proteolytic degradation products that appeared
during membrane preparation or treatment with the conventional SDS^PAGE loading buffer. These data resolve
discrepancies reported previously for the molecular size of RFC1. ß 2000 Elsevier Science B.V. All rights reserved.
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The reduced folate carrier (RFC1) is a member of
the major facilitator superfamily [1] and a major
transport route for folates that are critical for one-
carbon dependent biosynthetic reactions [2]. RFC1
mediates transport of a variety of antifolates as
well and impaired membrane transport due to de-
creased expression, or mutations, of RFC1 is an im-
portant basis for intrinsic and acquired drug resis-
tance [3^11]. Recently, RFC1 was also proposed to
play a major role in folate absorption in small
intestine [12,13]. Before RFC1 was cloned, a⁄nity
labeling was utilized to characterize the transporter.
Using the N-hydroxysuccinimide ester of tritiated
methotrexate (NHS-[3H]MTX), a protein with a
molecular weight of V36 kDa was speci¢cally la-
beled [14]. However, when NK-(4-amino-4-deoxy-10-
methylpteroyl)-NO-(4-azido-5-[125I]iodosalicylyl)-L-ly-
sine (APA-[125I]ASA-Lys) was employed, a 46-kDa
protein was identi¢ed, although a 38-kDa band was
also sometimes visible on SDS^PAGE [15,16]. A⁄n-
ity labeling with NHS-[3H]aminopterin of an L1210
variant overexpressing this transporter also labeled a
46-kDa protein [17]. The murine RFC1 was cloned
in 1994 and shown to encode a protein with a pre-
dicted molecular size of 58 kDa [18]. However, the
peptide expressed when RFC1 cDNA was trans-
fected into RFC1-null L1210 cells was also found
to be a 46-kDa protein based upon Western blot
analysis [8]. On the other hand, RFC1 expressed in
murine small intestinal cells was identi¢ed as a 58-
kDa protein [13].
This laboratory has developed polyclonal antibod-
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ies targeted to two di¡erent epitopes in RFC1. The
AE372 antibody recognizes the loop between the pre-
dicted sixth and seventh transmembrane domains
(Asp232 through Asp248), while the AE390 antibody
targets the distal C-terminus (Met499 through Ala512)
of RFC1. The peptides were synthesized by the Pro-
teomics facility at the Albert Einstein College of
Medicine Comprehensive Cancer Center and coupled
to keyhole limpet hemocyanin (Pierce). Antisera were
produced in rabbits by Covance (Denver, PA, USA)
and the antibodies puri¢ed with a⁄nity columns to
which the corresponding peptide antigens were cova-
lently linked to SulfoLink Coupling gel (Pierce). Cell
plasma membranes were prepared by Dounce ho-
mogenization under hypotonic conditions and subse-
quent sucrose gradient centrifugation [14]. Protein
concentrations were determined with the BCA Pro-
tein Assay kit (Pierce).
As shown in Fig. 1, lane 1, the AE372 antibody to
the loop detected proteins at 58 and 46 kDa, while
AE390 to the C-terminus detected only the 58-kDa
protein (lane 5) in L1210 cells. Both proteins were
missing in D10 cells (lanes 2 and 6), an MTX-resist-
ant L1210 cell line which does not express RFC1 due
to a homogeneous GCA mutation in the initiation
codon of translation [9]. Protein was highly expressed
in an RFC1-overproducing transfectant, MTXrA-
R16 (lanes 3 and 7), in which RFC1 activity and
message were 9- and 5-fold greater than in L1210
cells, respectively [5,19]. Again, the 58- and 46-kDa
proteins were detected with the loop antibody, but
only the 58-kDa protein was identi¢ed with the
C-terminus antibody. The amount of protein was
decreased in MTXrA cells from which MTXrA-R16
was derived, as compared to that in L1210 cells. The
signal produced with the AE390 antibody was stron-
ger than that with the AE372 antibody. If MTXrA-
R16 samples were overloaded on SDS^PAGE, an-
other product with a molecular weight of 12 kDa
was detected only with AE390 antibody, presumably
representing the C-terminus part of RFC1 (not
shown). In Western blot analyses from six separate
plasma membrane preparations from L1210 cells, the
pattern of double bands with the AE372 antibody
and a single band with the AE390 antibody was al-
ways observed; in two cases, the intensity of the
46-kDa band was much stronger than that of the
58-kDa band. These data, therefore, suggested that
RFC1 encodes a protein with a molecular size of
58 kDa as predicted from its cDNA and the
46-kDa protein may be a proteolytic product lacking
the C-terminus of RFC1 not detected by the AE390
antibody.
To establish whether partial degradation of RFC1
was associated with the method utilized to prepare
the plasma membrane fraction, another technique
was employed to determine if the degradation pro-
cess could be minimized. Total lysates from MTXrA-
R16, L1210 and MTXrA cells were prepared by brief
sonication of intact cells and then analyzed by West-
ern blots in the same way as the plasma membrane
samples. As shown in Fig. 2, RFC1 protein expres-
sion from MTXrA-R16 cells (lanes 1 and 4) was
much higher than from L1210 cells (lanes 2 and 5).
There was minimal detection of RFC1 in the
MTXrA cells (lanes 3 and 6). In all these cell lines,
Fig. 1. A representative Western blot analysis of plasma mem-
brane fractions using the AE372 antibody to the large loop be-
tween the sixth and seventh transmembrane domains, and the
AE390 antibody to the C-terminus. Plasma membranes from
L1210, D10, MTXrA-R16 and MTXrA cells were extracted as
reported, except a protease inhibitor cocktail (P8340, Sigma) at
a dilution of 1:1000 was used instead of 1 mM phenylmethyl-
sulfonyl£uoride [14]. Protein concentrations were determined
with the BCA Protein Assay kit (Pierce). The membrane pro-
teins were dissolved in a SDS^PAGE loading bu¡er (60 mM
Tris, 10% glycerol (v/v), 2% SDS and trace bromophenol, pH
6.8) without heating at 95‡C for 5 min and resolved on 12%
SDS^polyacrylamide gel. The proteins were transferred to
PVDF Transfer Membranes (Amersham) and processed by the
ECL Plus Western blotting detection system from Amersham.
The amounts of total plasma membrane protein loaded on the
SDS^polyacrylamide gel are indicated in the ¢gure. The data
shown are representative of six separate experiments.
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however, only protein with a molecular size of 58
kDa was detected with the AE372 antibody. This
was in contrast to the pattern found with the plasma
membrane preparations (Fig. 1), consistent with the
likelihood that 58-kDa protein was degraded during
the process of plasma membrane isolation.
The conventional method of preparing samples for
SDS^PAGE is to dissolve proteins in a loading bu¡-
er containing dithiothreitol (DTT) to break S^S
bonds and heat the solution for 5 min at 95‡C to
denature the protein. However, both DTT and heat
during preparation of samples profoundly a¡ected
the outcome of Western blot analysis of the plasma
membrane samples (Fig. 3). When DTT was included
in the loading bu¡er and the solution was heated at
95‡C, the AE372 antibody identi¢ed only one protein
at 38 kDa (lane 1), whereas AE390 labeled a weak
band at 58 kDa (lane 5). When samples were not
heated and DTT was omitted, there were bands at
46 and 58 kDa (lane 4) with the AE372 antibody and
one strong band at 58 kDa with the AE390 antibody
(lane 8) as in Fig. 1. The disappearance or decreased
intensity of the 46- and 58-kDa bands with DTT and
heat (lane 1 and lane 5) was probably due to oligo-
merization of proteins suggested by the smearing at
higher molecular weights (lane 5). Oligomerization
appeared to be accelerated by heating at 95‡C, since
the 46- and/or 58-kDa proteins were present when
DTT was included but heating was omitted (lanes 2
and 6). Heat-activated oligomerization was not de-
pendent on the presence of DTT as visualized in lane
7 of Fig. 3. Under these conditions, no speci¢c pro-
teins were identi¢ed. Hence, conditions in which
heating and DTT were excluded were optimal for
maximal preservation of RFC1 protein.
These observations may explain why only a V38-
kDa protein was detected when murine RFC1 was
Fig. 3. E¡ect of DTT in the SDS^PAGE loading bu¡er and
heating of the protein solution on Western blot analysis of plas-
ma membrane fractions. L1210 cell plasma membranes (as de-
scribed in the legend for Fig. 1) were treated with the SDS^
PAGE loading bu¡er with or without addition of 1.5% DTT.
The mixtures were either ¢rst heated at 95‡C for 5 min then
loaded on the 12% SDS^polyacrylamide gel, or loaded directly
on the gel with heating. The subsequent steps for Western blot
analysis follow the ECL Plus protocols from Amersham. The
same amount of plasma membrane (10 Wg) was loaded on each
lane. The data are representative of the results from three sepa-
rate experiments.
Fig. 2. Western Blot analysis of total lysates using the AE372
loop and AE390 C-terminus antibodies. MTXrA-R16, L1210
and MTXrA cells (3U107) were harvested, washed twice with
HEPES-bu¡ered saline (20 mM HEPES, 140 mM NaCl, 5 mM
KCl, 2 mM MgCl2, 5 mM glucose, pH 7.4) and suspended in
100 Wl of the same solution containing 10 Wl of protease inhibi-
tor (P8340, Sigma). The cell suspension was sonicated for 20 s
in a tube submerged in ice-water and mixed with 100 Wl of
2USDS^PAGE loading bu¡er (see the legend for Fig. 1) with-
out heating. Western blot analysis was carried out according to
the ECL Plus protocol from Amersham. The number of cells
from which the lysate loaded on the SDS^polyacrylamide was
obtained is indicated in the ¢gure. Data are representative of
two separate experiments.
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a⁄nity-labeled with NHS-[3H]MTX followed by
SDS^PAGE with DTT and heating [14] or why
when murine RFC1 was labeled with APA-
[125I]ASA-Lys, 38- and 46-kDa peptides were identi-
¢ed on SDS^PAGE in loading bu¡er containing
DTT heated to only 60‡C [15]. It is of interest that
heating was omitted in preparation of samples
for SDS^PAGE after a⁄nity labeling of RFC1
in L1210 cells and its variant with NHS-
[3H]aminopterin [17]. Hence, it is highly likely that
the 38-kDa protein represents a degradation product
of RFC1 associated with DTT treatment, probably
derived from the 46-kDa breakdown product and
not from the intact 58-kDa RFC1. Hence, treatment
of the total lysate, in which RFC1 was intact (Fig. 2),
with DTT without heating did not result in the ap-
pearance of 38-kDa peptide (data not shown).
These ¢ndings resolve the discrepancies in ob-
served molecular weights of RFC1 protein and sug-
gest that the proteins detected in murine L1210 leu-
kemia and small intestinal cells, which share a
molecular mass of 58 kDa, are identical. However,
RFC1-mediated in£ux in L1210 cells has an a⁄nity
for folic acid that is two orders of magnitude lower
than that of folate transport in intestinal cells with
an in£ux optimum at neutral pH as opposed to a
low-pH optimum in intestine [12,13,20]. The basis
for the very di¡erent transport properties in these
tissues remains to be determined.
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